cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.15468/dl.3jc7n2
title: Occurrence Download

description: A dataset containing 15 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Ageratum conyzoides",
 "Country is Lao People’s Democratic Republic",
 "HasCoordinate is true"
 ]
}

 The dataset includes 15 records from 9 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0020553-250717081556266/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.11588/duerer.online.687dd04650062
title: Christus in der Vorhölle, https://d-nb.info/gnd/1155557905
DOI: 10.11588/duerer.online.687dd047ce0c3
title: Christus in der Vorhölle, https://d-nb.info/gnd/1155557662
DOI: 10.11588/duerer.online.687dd0494a665
title: Die Kreuzabnahme, https://d-nb.info/gnd/1069334995
DOI: 10.11588/duerer.online.687dd04a29a0c
title: Die Kreuzabnahme, 51308
DOI: 10.11588/duerer.online.687dd04b9ab04
title: Die Kreuzabnahme, https://d-nb.info/gnd/1155559215
DOI: 10.11588/duerer.online.687dd04ceb107
title: Die Kreuzabnahme, https://d-nb.info/gnd/1159714959
DOI: 10.11588/duerer.online.687dd04e5c37c
title: Die Kreuzabnahme, https://d-nb.info/gnd/1155558693
DOI: 10.15468/dl.3q8pjf
title: Occurrence Download

description: A dataset containing 129 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Ageratum conyzoides",
 "Country is Madagascar",
 "HasCoordinate is true"
 ]
}

 The dataset includes 129 records from 16 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0020555-250717081556266/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.11588/duerer.online.687dd04fab94b
title: Die Kreuzabnahme, https://d-nb.info/gnd/1155558529
DOI: 10.11588/duerer.online.687dd05105874
title: Die Beweinung, https://d-nb.info/gnd/1069335258
DOI: 10.11588/duerer.online.687dd051eb3d1
title: Die Beweinung, 51619
DOI: 10.11588/duerer.online.687dd0534ef36
title: Die Beweinung, https://d-nb.info/gnd/1159715289
DOI: 10.11588/duerer.online.687dd054e1c8d
title: Die Beweinung, https://d-nb.info/gnd/1155560299
DOI: 10.11588/duerer.online.687dd05624ea4
title: Die Beweinung, https://d-nb.info/gnd/115556006X
DOI: 10.11588/duerer.online.687dd057addf9
title: Die Beweinung, https://d-nb.info/gnd/1155564111
DOI: 10.11588/duerer.online.687dd0591dfc3
title: Die Grablegung, https://d-nb.info/gnd/1069335584
DOI: 10.11588/duerer.online.687dd05a21733
title: Die Grablegung, 51940
DOI: 10.11588/duerer.online.687dd05bafe08
title: Die Grablegung, https://d-nb.info/gnd/1155769589
DOI: 10.15468/dl.2f3byy
title: Occurrence Download

description: A dataset containing 0 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Albizia lebbeck",
 "Country is Guyana",
 "HasCoordinate is true"
 ]
}

 The dataset includes 0 records from 0 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0020554-250717081556266/datasets/export for details.
DOI: 10.11588/duerer.online.687dd05d08e5f
title: Die Grablegung, https://d-nb.info/gnd/1159715645
DOI: 10.11588/duerer.online.687dd05e46855
title: Die Grablegung, https://d-nb.info/gnd/1155769074
DOI: 10.11588/duerer.online.687dd05f8e2f9
title: Die Auferstehung, https://d-nb.info/gnd/1069336092
DOI: 10.11588/duerer.online.687dd06090b6c
title: Die Auferstehung, 52207
DOI: 10.11588/duerer.online.687dd06208a77
title: Die Auferstehung, https://d-nb.info/gnd/1155771427
DOI: 10.11588/duerer.online.687dd0635296b
title: Die Auferstehung, https://d-nb.info/gnd/1155770412
DOI: 10.11588/duerer.online.687dd064d1926
title: Die Auferstehung, https://d-nb.info/gnd/1155770129
DOI: 10.11588/duerer.online.687dd0665e3b2
title: Christus erscheint seiner Mutter, https://d-nb.info/gnd/1069336734
DOI: 10.11588/duerer.online.687dd06752350
title: Christus erscheint seiner Mutter, 52457
DOI: 10.11588/duerer.online.687dd068aa0fd
title: Christus erscheint seiner Mutter, https://d-nb.info/gnd/1159716404
DOI: 10.11588/duerer.online.687dd069e2c58
title: Christus erscheint seiner Mutter, https://d-nb.info/gnd/1155780477
DOI: 10.11588/duerer.online.687dd06acbe45
title: Christus erscheint Magdalena, https://d-nb.info/gnd/1069336963
DOI: 10.11588/duerer.online.687dd06bab29b
title: Christus erscheint Magdalena, 52689
DOI: 10.11588/duerer.online.687dd06d2c4f1
title: Christus erscheint Magdalena, https://d-nb.info/gnd/1155781309
DOI: 10.11588/duerer.online.687dd06e81514
title: Christus erscheint Magdalena, https://d-nb.info/gnd/1155781163
DOI: 10.11588/duerer.online.687dd06fc090a
title: Christus in Emaus, https://d-nb.info/gnd/1069337803
DOI: 10.11588/duerer.online.687dd070889e8
title: Christus in Emaus, 52889
DOI: 10.11588/duerer.online.687dd071e7dd2
title: Christus in Emaus, https://d-nb.info/gnd/1155787447
DOI: 10.11588/duerer.online.687dd0735a579
title: Der ungläubige Thomas, https://d-nb.info/gnd/1069344028
DOI: 10.11588/duerer.online.687dd07451515
title: Der ungläubige Thomas, 53044
DOI: 10.11588/duerer.online.687dd075cb666
title: Der ungläubige Thomas, https://d-nb.info/gnd/1155788265
DOI: 10.11588/duerer.online.687dd0772eda6
title: Der ungläubige Thomas, https://d-nb.info/gnd/1155788478
DOI: 10.11588/duerer.online.687dd078994f4
title: Die Himmelfahrt, https://d-nb.info/gnd/1069345563
DOI: 10.11588/duerer.online.687dd079780d0
title: Die Himmelfahrt, 53264
DOI: 10.11588/duerer.online.687dd07ac576c
title: Die Himmelfahrt, https://d-nb.info/gnd/1155939115
DOI: 10.15468/dl.dvfgqm
title: Occurrence Download

description: A dataset containing 100 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Ageratum conyzoides",
 "Country is Malawi",
 "HasCoordinate is true"
 ]
}

 The dataset includes 100 records from 14 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0020556-250717081556266/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.11588/duerer.online.687dd07c146c5
title: Die Sendung des Heiligen Geistes, https://d-nb.info/gnd/1069346187
DOI: 10.11588/duerer.online.687dd07cd5df8
title: Die Sendung des Heiligen Geistes, 53415
DOI: 10.11588/duerer.online.687dd07e31d1a
title: Die Sendung des Heiligen Geistes, https://d-nb.info/gnd/115972699X
DOI: 10.11588/duerer.online.687dd07f9b418
title: Die Sendung des Heiligen Geistes, https://d-nb.info/gnd/1155940563
DOI: 10.60645/bdc-m4hn-t6zt
title: NHLBI TOPMed: Pediatric Asthma Controller Trial (PACT)

description: After a 2-4 week assessment/characterization run-in period, 6-14 year-old children who met NAEPP criteria for mild-moderate persistent asthma specifically based on symptom criteria and methacholine PC20 ≤ 12.5 mg/ml and FEV1 ≥ 80% were randomized to one of the three active treatment arms for 12 months. Randomization was stratified according to clinical center, bronchodilator response (< 12% or ≥ 12%), race (Caucasian or non-Caucasian), and methacholine PC20 (< 2 or ≥ 2 mg/ml). The primary outcome variable was the proportion of asthma-free days during the 12-month treatment period. Secondary outcomes included other measures of asthma control (percentage of rescue-free days, albuterol-free days, and episode-free days; the number of asthma exacerbations requiring prednisone therapy and the time to the first asthma exacerbation), forced oscillation and spirometry, reversibility (FEV1 pre- and post 2 puffs of albuterol MDI), methacholine PC20, exhaled nitric oxide, and asthma-related quality of life.
DOI: 10.60645/bdc-n872-741l
title: NHLBI TOPMed: Pediatric Asthma Controller Trial (PACT)

description: 
After a 2-4 week assessment/characterization run-in period, 6-14 year-old children who met NAEPP criteria for mild-moderate persistent asthma specifically based on symptom criteria and methacholine PC20 &#8804; 12.5 mg/ml and FEV1 &#8805; 80% were randomized to one of the three active treatment arms for 12 months. Randomization was stratified according to clinical center, bronchodilator response (&lt; 12% or &#8805; 12%), race (Caucasian or non-Caucasian), and methacholine PC20 (&lt; 2 or &#8805; 2 mg/ml). The primary outcome variable was the proportion of asthma-free days during the 12-month treatment period. Secondary outcomes included other measures of asthma control (percentage of rescue-free days, albuterol-free days, and episode-free days; the number of asthma exacerbations requiring prednisone therapy and the time to the first asthma exacerbation), forced oscillation and spirometry, reversibility (FEV1 pre- and post 2 puffs of albuterol MDI), methacholine PC20, exhaled nitric oxide, and asthma-related quality of life.
DOI: 10.60645/bdc-xg93-2844
title: NHLBI TOPMed: TReating Children to Prevent EXacerbations of Asthma (TREXA)

description: TREXA is a 44-week randomized, double-blind, double-masked, four-treatment, parallel trial that will evaluate the weaning strategy that provides the best protection against the development of exacerbations in children whose asthma is acceptably controlled on a low dose of ICS (per NAEPP guidelines). Following the 4 weeks of the run-in period on a 1x dose of ICS (100 µg fluticasone b.i.d. or its equivalent), children who do not meet the definition of acceptable asthma control will be randomized to the parallel BADGER protocol; those who meet the definition of acceptable asthma control will be enrolled into the 44-week treatment phase of the study. The primary outcome measure will be time to first exacerbation requiring a prednisone course.
DOI: 10.60645/bdc-qabg-ymd8
title: NHLBI TOPMed: TReating Children to Prevent EXacerbations of Asthma (TREXA)

description: 
TREXA is a 44-week randomized, double-blind, double-masked, four-treatment, parallel trial that will evaluate the weaning strategy that provides the best protection against the development of exacerbations in children whose asthma is acceptably controlled on a low dose of ICS (per NAEPP guidelines). Following the 4 weeks of the run-in period on a 1x dose of ICS (100 &#181;g fluticasone b.i.d. or its equivalent), children who do not meet the definition of acceptable asthma control will be randomized to the parallel [BADGER](./study.cgi?study_id=phs001728) protocol; those who meet the definition of acceptable asthma control will be enrolled into the 44-week treatment phase of the study. The primary outcome measure will be time to first exacerbation requiring a prednisone course.
DOI: 10.60645/bdc-8202-v962
title: NHLBI TOPMed: TReating Children to Prevent EXacerbations of Asthma (TREXA)

description: 
TREXA is a 44-week randomized, double-blind, double-masked, four-treatment, parallel trial that will evaluate the weaning strategy that provides the best protection against the development of exacerbations in children whose asthma is acceptably controlled on a low dose of ICS (per NAEPP guidelines). Following the 4 weeks of the run-in period on a 1x dose of ICS (100 &#181;g fluticasone b.i.d. or its equivalent), children who do not meet the definition of acceptable asthma control will be randomized to the parallel [BADGER](./study.cgi?study_id=phs001728) protocol; those who meet the definition of acceptable asthma control will be enrolled into the 44-week treatment phase of the study. The primary outcome measure will be time to first exacerbation requiring a prednisone course.
DOI: 10.15468/dl.35ahe3
title: Occurrence Download

description: A dataset containing 66 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Ptychococcus paradoxus",
 "HasCoordinate is true",
 "BasisOfRecord is one of (Specimen)"
 ]
}

 The dataset includes 66 records from 8 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0016311-260129131611470/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.60645/bdc-38fm-0ghy
title: Profiles of exRNA in CSF and Plasma from Subarachnoid Hemorrhage Patients

description: 
Brain injury resulting from hemorrhagic stroke is clinically challenging to manage and results in high rates of morbidity and mortality. The pathophysiology of brain damage resulting from aneurysmal subarachnoid hemorrhage (aSAH) is largely unknown, and methods to treat and monitor patients are variable with no meaningful correlations to patient outcome. Prediction of patient risk for serious neurological complications is currently a significant clinical obstacle. An extracellular RNA (exRNA) biomarker to predict onset and severity of brain damage would improve patient outcomes. We sequenced plasma and CSF samples from adult patients with SAH. Samples were collected from post bleed day 1 to day 7. Total exRNA was isolated from each sample. In addition, we prepared a subset of 140 CSF samples, isolating the RNA contained within extracellular vesicles and vesicle-depleted biofluid.
DOI: 10.60645/bdc-q39t-vma1
title: Molecular Genetics of Heterotaxy and Related Congenital Heart Defects

description: 
Heterotaxy syndrome is a congenital anomaly syndrome accompanied by thoracic and abdominal situs abnormalities. The study cohort comprises of individuals with heterotaxy or related congenital heart disease (CHD) who have undergone exome sequencing. The purpose of the study is to elucidate the molecular genetics of the disorder as well as contribute to knowledge about the biology of normal and abnormal development of left-right anatomic asymmetry. These results will further help delineate genotype-phenotype associations and provide important information on the causes, management, and prognosis of heterotaxy syndrome.
DOI: 10.60645/bdc-7bo8-3lc2
title: miRNA Profiling of Maternal and Non-Maternal Healthy Adult Blood Plasma Using Small RNA-Sequencing

description: 
We compared several performance characteristics of four miRNA profiling methods: small RNA-sequencing, HTG EdgeSeq, Abcam FirePlex, and NanoString nCounter. We used pools of synthetic miRNAs and extracellular RNA from healthy individuals to assess these characteristics.
DOI: 10.60645/bdc-h8d9-z503
title: NHLBI TOPMed - NHGRI CCDG: UCSF Atrial Fibrillation Study

description: 
The University of California San Francisco (UCSF) Cardiovascular Research Institute (CVRI) Resource in Arteriosclerosis and Metabolic Disease is an ongoing multi-ethnic study of adults &#8805; 18 years of age which was started in 1989 and now includes 28,000 participants recruited from the UCSF medical system. Within the Resource lies data and biospecimens from nearly 1,000 patients presenting to the electrophysiology laboratory for electrophysiology procedures that were densely phenotyped for electrophysiologic characteristics with biospecimens collected from various intra and extra-cardiac chambers. Phenotyping of all participants was achieved via interview and review of medical records. A subset of 113 participants with early-onset atrial fibrillation underwent WGS as a part of the TOPMed Program.
DOI: 10.60645/bdc-2q1d-81m2
title: LungMAP: Molecular Atlas of Lung Development - Human Lung Tissue

description: 
Mammalian fetal lung development is a complex biological process. Despite considerable progress, a comprehensive understanding of the dynamic regulatory networks that govern postnatal alveolar lung development is still lacking. The purpose of this study as part of the LungMAP consortium ([www.lungmap.net](https://lungmap.net/)) is to understand the transcriptional changes in the process of mammalian lung development.
DOI: 10.60645/bdc-20y8-84b7
title: LungMAP: Molecular Atlas of Lung Development - Human Lung Tissue

description: 
Mammalian fetal lung development is a complex biological process. Despite considerable progress, a comprehensive understanding of the dynamic regulatory networks that govern postnatal alveolar lung development is still lacking. The purpose of this study as part of the LungMAP consortium ([www.lungmap.net](https://lungmap.net/)) is to understand the transcriptional changes in the process of mammalian lung development.
DOI: 10.60645/bdc-p3um-9049
title: NHLBI TOPMed: Genomic Summary Results for the Trans-Omics for Precision Medicine Program

description: 
The NHLBI Trans-Omics for Precision Medicine (TOPMed) program aims to identify the genetic basis of variation in biomedical phenotypes, with emphasis on those related to heart, lung, blood and sleep disorders, as part of a broader [Precision Medicine Initiative](https://www.nhlbi.nih.gov/science/precision-medicine-activities). The TOPMed program has provided whole genome sequencing (WGS) to over 80 different studies that had previously recruited participants and collected extensive phenotype data. Many TOPMed investigators affiliated with these studies have organized their activities into phenotype-focused Working Groups and have developed genotype-phenotype association projects. These analyses have resulted in valuable cross-study Genomic Summary Results (GSR) that include whole genome association test results of both common and rare variants. Most of the analyses include data from multiple studies, some of which are based on sensitive populations, precluding public sharing of GSR. This dbGaP accession provides a mechanism for sharing sensitive GSR, using the controlled-access mechanisms of dbGaP to provide protections for sensitive populations.
DOI: 10.60645/bdc-gw7q-f0iy
title: Aptamer Proteomics of Cardiometabolic and Renal Traits in African Americans

description: 
This sub-study [phs002256](./study.cgi?study_id=phs002256) Cardiometabolic Renal Proteomics study contains molecular data. Summary level phenotypes for the NHLBI JHS cohort participants can be viewed at the top-level study page [phs000286](./study.cgi?study_id=phs000286) JHS Cohort. Individual level phenotype data and molecular data for all JHS Cohort top-level study and substudies are available by requesting Authorized Access to the NHLBI JHS Cohort [phs000286](./study.cgi?study_id=phs000286) study.<br>
DOI: 10.5281/zenodo.18505023
title: Copa

description: Copa procedente del Castillejo de los Güajares (Güájar Faraguit). Presenta una forma con un borde exvasado de labio redondeado. El cuello continua la tendencia del borde hasta llegar al engrosamiento que forma el hombro. El cuerpo es estrecho y de forma redondeada. Da paso a un pie que primero se estrecha y luego se engrosa hasta acabar en una superficie plana. En esta superficie aparecen tres apendices que sustentan todo el cuerpo.

Cronología: XII - XIV

Fotografías y modelo: (http://sketchfab.com/ibarramedinaA)

Este modelo forma parte de CEGRAM (Proyecto PID2022-140442NA-I00 financiado por MICIU/AEI/10.13039/501100011033/ y por FEDER, UE) e iCERAAM (Proyecto de Innovación docente: Ceramoteca medieval y moderna. Un instrumento docente y de divulgación. ICERAMM (PIB Tipo A nº 24-199), financiado por la Universidad de Granada)
DOI: 10.60645/bdc-a9nu-0674
title: Aptamer Proteomics of Cardiometabolic and Renal Traits in African Americans

description: 
This sub-study [phs002256](./study.cgi?study_id=phs002256) Cardiometabolic Renal Proteomics study contains molecular data. Summary level phenotypes for the NHLBI JHS cohort participants can be viewed at the top-level study page [phs000286](./study.cgi?study_id=phs000286) JHS Cohort. Individual level phenotype data and molecular data for all JHS Cohort top-level study and substudies are available by requesting Authorized Access to the NHLBI JHS Cohort [phs000286](./study.cgi?study_id=phs000286) study.<br>
DOI: 10.5281/zenodo.18505022
title: Copa

description: Copa procedente del Castillejo de los Güajares (Güájar Faraguit). Presenta una forma con un borde exvasado de labio redondeado. El cuello continua la tendencia del borde hasta llegar al engrosamiento que forma el hombro. El cuerpo es estrecho y de forma redondeada. Da paso a un pie que primero se estrecha y luego se engrosa hasta acabar en una superficie plana. En esta superficie aparecen tres apendices que sustentan todo el cuerpo.

Cronología: XII - XIV

Fotografías y modelo: (http://sketchfab.com/ibarramedinaA)

Este modelo forma parte de CEGRAM (Proyecto PID2022-140442NA-I00 financiado por MICIU/AEI/10.13039/501100011033/ y por FEDER, UE) e iCERAAM (Proyecto de Innovación docente: Ceramoteca medieval y moderna. Un instrumento docente y de divulgación. ICERAMM (PIB Tipo A nº 24-199), financiado por la Universidad de Granada)
DOI: 10.60645/bdc-z732-0fr2
title: Aptamer Proteomics of Cardiometabolic and Renal Traits in African Americans

description: 
This sub-study [phs002256](./study.cgi?study_id=phs002256) Cardiometabolic Renal Proteomics study contains molecular data. Summary level phenotypes for the NHLBI JHS cohort participants can be viewed at the top-level study page [phs000286](./study.cgi?study_id=phs000286) JHS Cohort. Individual level phenotype data and molecular data for all JHS Cohort top-level study and substudies are available by requesting Authorized Access to the NHLBI JHS Cohort [phs000286](./study.cgi?study_id=phs000286) study.<br>
DOI: 10.60645/bdc-go37-a672
title: Aptamer Proteomics of Cardiometabolic and Renal Traits in African Americans

description: 
This sub-study [phs002256](./study.cgi?study_id=phs002256) Cardiometabolic Renal Proteomics study contains molecular data. Summary level phenotypes for the NHLBI JHS cohort participants can be viewed at the top-level study page [phs000286](./study.cgi?study_id=phs000286) JHS Cohort. Individual level phenotype data and molecular data for all JHS Cohort top-level study and substudies are available by requesting Authorized Access to the NHLBI JHS Cohort [phs000286](./study.cgi?study_id=phs000286) study.<br>
DOI: 10.60645/bdc-o2i6-3j06
title: PETAL Network: Outcomes Related to COVID-19 Treated With Hydroxychloroquine Among Inpatients With Symptomatic Disease (ORCHID) Trial

description: 
ORCHID was a multicenter, blinded, placebo-controlled randomized trial conducted at 34 hospitals in the US between April 2 and June 19, 2020. Adults hospitalized with respiratory symptoms from severe acute respiratory syndrome coronavirus 2 infection were enrolled, with the last outcome assessment on July 17, 2020. The planned sample size was 510 patients with five interim analyses; however, the trial was stopped at the fourth interim analysis for futility with a sample size of 479 patients.

The distribution of the day 14 clinical status score (measured using a 7-category ordinal scale) was not significantly different for patients randomized to receive hydroxychloroquine compared with placebo.

Instructions for requesting individual-level data are available on BioData Catalyst at [https://biodatacatalyst.nhlbi.nih.gov/resources/data/](https://biodatacatalyst.nhlbi.nih.gov/resources/data/). Apply for data access in dbGaP. Upon approval, users may begin accessing requested data in BioData Catalyst. For questions about availability, you may contact the BioData Catalyst team at [https://biodatacatalyst.nhlbi.nih.gov/contact](https://biodatacatalyst.nhlbi.nih.gov/contact).